Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Sencure logo — Integrated Biosensor Technology

Sencure

Integrated Biosensor Technology

Founded 2021 The Netherlands The Netherlands 23 employees Series A Total: $6.50M Health Care, Medical Devices

General Information

Company Name Sencure
Founded Year 2021
Location The Netherlands The Netherlands
Employees 23
Industries Health Care, Medical Devices
Funding Stage Series A
Business Model B2B, D2C, B2D
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Sencure. To contact Sencure, visit sencure.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sencure compare?

A PDF of Sencure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sencure soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sencure

Sencure, established in 2021 and headquartered in The Netherlands, is an emerging player in the Health Care sector, particularly in Medical Devices. Specializing in integrated biosensor technology, Sencure develops chips designed to measure electrophysiological parameters innovatively and minimally affect patient lifestyles.

Pushing forward the possibilities of wearable health tech, Sencure's mission lies in enhancing patient compliance without compromising on technological advancement. By deeply understanding the needs of both healthcare providers and their patients, the company aims to transform wearable health solutions.

Notably, Sencure secured a €5.00M Series A investment on 20 July 2023, with backing from Cottonwood Technology Fund. This financial endorsement reflects investor confidence in its commercial potential and innovative merits.

For investors, Sencure represents a compelling opportunity within the dynamic intersection of healthcare innovation and wearable tech, poised to reshape patient monitoring and care.

Business keywords: Integrated Biosensor Technology, Electrophysiological Measurement, Wearable Health Solutions, IC Design for Medical Devices, Remote Patient Monitoring, Healthcare Wearables, Disposable Medical Patches, Low-power Analog Front-ends, Dry Electrode Technology, Amplifier Technology, Electroencephalography (EEG), Electrocardiography (ECG), Electromyography (EMG), Clinical Research Solutions, Preventative Healthcare Technology

Services & Products

Development of integrated circuits for medical and wearable technology
Research and development in low power, high-performance analog technology
Advanced sensor solutions for health monitoring

Target Customers

Medical Device Companies Health-Tracking Device Manufacturers Healthcare Innovators Research Institutions in MedTech

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €5.00M 1
Cottonwood Technology Fund
Cottonwood Technology Fund
20 Jul 2023
Seed Round €1.50M 2
Cottonwood Technology Fund Lumana Invest
Cottonwood Technology Fund, Lumana Invest
28 Apr 2021

Sencure Alternatives & Competitors

View All Alternatives
Sencure vs
Tenovi, an Inc. 5000 Company
Tenovi, an Inc. 5000 Company United States

Improving lives by simplifying remote care | Inc. 5000 #55 in the US, #2 in Boston Metro, #1 in NH a...

Series A
44 employees
Health Care, Information Technology
Sencure vs
CardiacSense
CardiacSense Israel

First medical watch for long-term continuous vital signs monitoring and real time arrhythmia detecti...

Series A
40 employees
Biotechnology, Digital Health
Sencure vs
Strados Labs
Strados Labs United States

Digital Lung Acoustics for Better Insight | Cough, Wheeze, Crackles

Venture round
47 employees
AI, Digital Health
View all alternatives

FAQ About Sencure

Integrated Biosensor Technology
Sencure was founded in 2021.
Sencure is headquartered in The Netherlands.
Sencure operates in Health Care and Medical Devices. Its work centres on Integrated Biosensor Technology, Electrophysiological Measurement, Wearable Health Solutions and IC Design for Medical Devices. Its customers include Medical Device Companies, Health-Tracking Device Manufacturers and Healthcare Innovators.
Sencure has a B2B, D2C and B2D business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Sencure has approximately 23 employees.
Sencure has completed 2 funding rounds, raising a total of $6.50M. The latest funding stage is Series A.
Sencure offers: Development of integrated circuits for medical and wearable technology, Research and development in low power, high-performance analog technology, Advanced sensor solutions for health monitoring.
Top alternatives and competitors to Sencure include Tenovi, an Inc. 5000 Company, CardiacSense, Strados Labs, Vivalink, Mode Sensors. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sencure and Tenovi, an Inc. 5000 Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sencure, https://bouncewatch.com/company/sencure, updated 23 February 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes